Advancing Cancer Care

About CancerX

CancerX is a groundbreaking public-private partnership designed to accelerate innovation in the fight against cancer. Hosted by the Moffitt Cancer Center and launched in collaboration with the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH) as part of the InnovationX program, CancerX was created to tackle the intractable challenges faced by patients and families living with cancer.

Our mission is to harness our collective superpowers as a public-private partnership to rapidly pioneer and accelerate access to innovative digital solutions that can improve both the experience and effectiveness of cancer care By combining the expertise of digital medicine and oncology, CancerX leverages the Moffitt Cancer Center’s proven ability to convene multi-stakeholder experts, including government partners, to drive digital solutions that will reduce cancer’s incidence and burden for all people.

LEAD

Demonstrate CancerX as the global leader in advancing digital innovation in oncology.

UNITE

Activate the ecosystem by fostering a dynamic innovator community for collaborative knowledge sharing, leveraging national platforms and US government partnerships to enhance outcomes through combined public and private sector strengths.

EMPOWER

Identify, support, grow, and implement world-class digital solutions in the market dedicated to reducing the burden of cancer for all people.

Screening & Early Diagnostics

Treatment Decision & Monitoring

Treatment Innovation

Access and Patient Experience

Xavier Avat, MBA, MBE

Chair of Steering Committee - EVP & Chief Business Officer at Moffitt Cancer Center

Brian Gonzalez PhD

Co-Chair of Steering Committee - Associate Center Director for Research Career Development at Moffitt Cancer Center

Shirin Ahmed, MBA

Head of Medical Innovation, Strategy and Operations at AstraZeneca

Rasu Shrestha, MD, MBA

Chief Innovation & Commercialization Officer at Advocate Health

Ben Moscovitch, MA

Healthcare and Life Science Public Policy Lead, Americas at Amazon Web Services (AWS)

Sally Werner, MS

Chief Executive Officer at Cancer Support Community

Cait Brumme, MBA

Chief Executive Officer at MassChallenge

Omid Toloui, MBA, MPH

Vice President of Innovation at Elevance Health

Andrea Downing

Chief Executive Officer at Light Collective

Matt Bettonville

Investor at Yosemite

Mary Tolikas, PhD, MBA

Senior VP and CIO at Dana-Farber Cancer Institute

Ashita S. Batavia, MD, MS

Head of Hematology & Oncology Data Sciences, Research & Development at J&J innovative Medicine

Stephen Konya

Chief, Innovation and Strategic Partnerships at U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Technology Policy (ASTP)

Edmondo Robinson, MD, MBA, FACP

Founder/CEO at Downeast Digital

Grace Cordovano, PhD, BCPA

CancerX Fellow, Board Certified Patient Advocate at Enlightening Results

Nainesh Parikh, MD, MBA

Chair, Accelerator Selection Committee

Kamal Jethwani, MD MPH

CancerX Lead

Corinne Leach, PhD, MPH, FGSA

Director, CancerX Governance

Alex Pelletier, MBA

Director, CancerX Accelerator

Eliza Dewey, MPH

CancerX Accelerator Startup Lead

Jayson Sterba, MPH

CancerX Partnerships Lead

Sarah Boone, PhD, MBE

CancerX Programming Lead

Shatana Ellison

CancerX - Community and Program Manager

Alex Barker

CancerX Technology Lead

Rakesh Ramaswamy, MS

CancerX Memberships Lead

Vrushali Malpelkar

CancerX Events Lead

Jessca Rancier-Floyd

CancerX Marketing Lead

Shaini Sarker, MBA

CancerX Programming

Kunal Dhir, MBA

CancerX Programming

Amanda Starling

CancerX Programming

The future of CancerX is bright as we continue to lead the way in digital innovation within oncology.

Building on successful demonstration projects and our inaugural accelerator cohort, we are making strides in transforming cancer care.

Our collaborative approach brings together a diverse community of innovators, clinicians, and organizations, creating a powerful ecosystem that fosters progress.

As CancerX grows, we remain committed to accelerating the digital revolution in oncology, driving improvements in patient care, access, and outcomes for all.